Literature DB >> 19410681

Rheumatic mitral valve disease: current surgical status.

Mustafa Zakkar1, Emre Amirak, K M John Chan, Prakash P Punjabi.   

Abstract

Rheumatic heart disease is the most serious sequelae of rheumatic fever occurring in approximately 30% of rheumatic fever patients. Patients with acute rheumatic fever may develop varying degrees of pancarditis with associated valve disease, heart failure, and pericarditis. Worldwide, rheumatic heart disease remains a major health problem although its prevalence in the developed countries is much reduced. Involvement of the mitral valve results in mitral regurgitation and/or stenosis. Where surgery is indicated, mitral valve replacement is usually necessary although in some cases, mitral valve repair is possible.

Entities:  

Mesh:

Year:  2009        PMID: 19410681     DOI: 10.1016/j.pcad.2008.08.008

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  9 in total

1.  Mitral valve repair in the treatment of mitral regurgitation.

Authors:  Blase A Carabello
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-12

2.  Health-related quality of life of patients after mechanical valve replacement surgery for rheumatic heart disease in a developing country.

Authors:  Linda J Thomson Mangnall; David W Sibbritt; Margaret Fry; Melanie Windus; Robyn D Gallagher
Journal:  Heart Asia       Date:  2014-12-09

3.  A Novel Rheumatic Mitral Valve Disease Model with Ex Vivo Hemodynamic and Biomechanical Validation.

Authors:  Matthew H Park; Pearly K Pandya; Yuanjia Zhu; Danielle M Mullis; Hanjay Wang; Annabel M Imbrie-Moore; Robert Wilkerson; Mateo Marin-Cuartas; Y Joseph Woo
Journal:  Cardiovasc Eng Technol       Date:  2022-08-08       Impact factor: 2.305

4.  Intraoperative Evaluation of Mitral Stenosis by Transesophageal Echocardiography.

Authors:  Anne D Cherry; Cory D Maxwell; Alina Nicoara
Journal:  Anesth Analg       Date:  2016-07       Impact factor: 5.108

5.  Subclinical right ventricular dysfunction in patients with mitral stenosis.

Authors:  Karima Taamallah; T Y Jabloun; M Guebsi; N Hajlaoui; D Lahidheb; W Fehri
Journal:  J Echocardiogr       Date:  2022-01-18

6.  A review of valve surgery for rheumatic heart disease in Australia.

Authors:  Elizabeth Anne Russell; Lavinia Tran; Robert A Baker; Jayme S Bennetts; Alex Brown; Christopher Michael Reid; Robert Tam; Warren Frederick Walsh; Graeme Paul Maguire
Journal:  BMC Cardiovasc Disord       Date:  2014-10-02       Impact factor: 2.298

7.  Value of pulmonary artery pressure in predicting in-hospital and one-year mortality after valve replacement surgery in middle-aged and aged patients with rheumatic mitral disease: an observational study.

Authors:  Lei Jiang; Xue-Biao Wei; Peng-Cheng He; Du Feng; Yuan-Hui Liu; Jin Liu; Ji-Yan Chen; Dan-Qing Yu; Ning Tan
Journal:  BMJ Open       Date:  2017-05-10       Impact factor: 2.692

8.  ANP and BNP plasma levels in patients with rheumatic mitral stenosis after percutaneous balloon mitral valvuloplasty.

Authors:  Łukasz Mazurkiewicz; Witold Rużyłło; Zbigniew Chmielak; Ewa Opalińska-Ciszek; Jadwiga Janas; Piotr Hoffman; Tomasz Hryniewiecki; Jacek Grzybowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-03-10       Impact factor: 1.426

9.  Predictors of Mortality in Patients Undergoing Mitral Valve Replacement.

Authors:  Muhammad Farhan Khan; Muhammad Shahzeb Khan; Faizan Imran Bawany; Mudassir Iqbal Dar; Mehwish Hussain; Saima Farhan; Kaneez Fatima; Khizar Hamid; Mohammad Hussham Arshad; Maira Aziz; Uswah Siddiqi; Nashit Irfan Aziz; Muhammad Bazil Musharraf; Abdul Bari Khan
Journal:  Glob J Health Sci       Date:  2015-06-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.